ONCONIX: A revolutionary organoid culturing and drug efficacy testing platform for personalized response prediction to cancer therapies (Innolink: 101

• Forschungsstelle: INNOSUISSE
• Projektnummer: 101.951 IP-LS
• Projekttitel Englisch: ONCONIX: A revolutionary organoid culturing and drug efficacy testing platform for personalized response prediction to cancer therapies (Innolink: 101

Schlüsselwörter (Englisch)

Life sciences, Personalised medicine

Abstract (Englisch)

We will deliver ONCONIX: a highly innovative personalized treatment-response prediction platform for oncology based on uniquely rapid patient-derived organoid cultures and in-house developed machine learning models. Here, we will perform a non-interventional proof-of-concept study in bladder cancer.